§ Funding Round
Series D funding round for TME Pharma raising $41M in May 2010
Series D funding round for TME Pharma raising $41M in May 2010
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
FCP OP MEDICAL BioHealth-Trends | — | — |
| Organization | — | |
IBG Sachsen-Anhalt | — | — |
ngn capitalLEAD | Organization | — |
| Organization | — | |
| Organization | — | |
The Dow Chemical Company | — | — |
| Organization | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$97.3M
Top Valuation
-
TME Pharma raised $41M in a Series D round.
The round was announced on 05/01/10.
The round was led by ngn capital.
